0001567619-22-006334.txt : 20220304 0001567619-22-006334.hdr.sgml : 20220304 20220304090338 ACCESSION NUMBER: 0001567619-22-006334 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 EFFECTIVENESS DATE: 20220304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncXerna Therapeutics, Ltd. CENTRAL INDEX KEY: 0001914838 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435862 FILM NUMBER: 22712219 BUSINESS ADDRESS: STREET 1: 300 FIFTH AVENUE STREET 2: SUITE 6040 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 907-7810 MAIL ADDRESS: STREET 1: 300 FIFTH AVENUE STREET 2: SUITE 6040 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001914838 OncXerna Therapeutics, Ltd. 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 (781) 907-7810 CAYMAN ISLANDS Oncologie, Ltd. Oncxerna Therapeutics, Ltd. None Corporation true 2018 Laura Benjamin 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 Director Peter Bisgaard 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 Director Vincent Cheung 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 Director Benjamin Chen 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 Director Chrystiyna Bedrij 300 Fifth Avenue, Suite 6040 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2022-02-17 false true false 0 100000000 30000000 70000000 false 4 0 0 0 false OncXerna Therapeutics, Ltd. /s/ Laura Benjamin, Ph.D. Laura Benjamin, Ph.D. Director 2022-03-03